Nothing Special   »   [go: up one dir, main page]

PT3573948T - Métodos de preparação de derivados de benzodiazepina citotóxicos - Google Patents

Métodos de preparação de derivados de benzodiazepina citotóxicos

Info

Publication number
PT3573948T
PT3573948T PT187043526T PT18704352T PT3573948T PT 3573948 T PT3573948 T PT 3573948T PT 187043526 T PT187043526 T PT 187043526T PT 18704352 T PT18704352 T PT 18704352T PT 3573948 T PT3573948 T PT 3573948T
Authority
PT
Portugal
Prior art keywords
methods
benzodiazepine derivatives
cytotoxic benzodiazepine
preparing cytotoxic
preparing
Prior art date
Application number
PT187043526T
Other languages
English (en)
Original Assignee
Immunogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunogen Inc filed Critical Immunogen Inc
Publication of PT3573948T publication Critical patent/PT3573948T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/13Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
    • C07C205/19Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups bound to carbon atoms of six-membered aromatic rings and hydroxy groups bound to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06Preparation of nitro compounds
    • C07C201/16Separation; Purification; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06Preparation of nitro compounds
    • C07C201/12Preparation of nitro compounds by reactions not involving the formation of nitro groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • C07D207/444Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5
    • C07D207/448Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide
    • C07D207/452Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide with hydrocarbon radicals, substituted by hetero atoms, directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04Dimeric indole alkaloids, e.g. vincaleucoblastine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
PT187043526T 2017-01-25 2018-01-24 Métodos de preparação de derivados de benzodiazepina citotóxicos PT3573948T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762450270P 2017-01-25 2017-01-25

Publications (1)

Publication Number Publication Date
PT3573948T true PT3573948T (pt) 2023-01-11

Family

ID=61189535

Family Applications (1)

Application Number Title Priority Date Filing Date
PT187043526T PT3573948T (pt) 2017-01-25 2018-01-24 Métodos de preparação de derivados de benzodiazepina citotóxicos

Country Status (22)

Country Link
US (4) US10385071B2 (pt)
EP (2) EP4148044A1 (pt)
JP (3) JP7066725B2 (pt)
KR (2) KR20230005410A (pt)
CN (3) CN110225904B (pt)
AU (3) AU2018213202B2 (pt)
CA (1) CA3050262A1 (pt)
DK (1) DK3573948T3 (pt)
ES (1) ES2935346T3 (pt)
FI (1) FI3573948T3 (pt)
HR (1) HRP20230002T1 (pt)
HU (1) HUE060746T2 (pt)
IL (3) IL287405B (pt)
LT (1) LT3573948T (pt)
PL (1) PL3573948T3 (pt)
PT (1) PT3573948T (pt)
RS (1) RS63871B1 (pt)
RU (2) RU2021138005A (pt)
SG (1) SG11201906666QA (pt)
SI (1) SI3573948T1 (pt)
TW (3) TW202400551A (pt)
WO (1) WO2018140435A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3573948T3 (pl) 2017-01-25 2023-01-30 Immunogen, Inc. Sposoby otrzymywania cytotoksycznych pochodnych benzodiazepiny
AU2019381628A1 (en) * 2018-11-12 2021-05-27 Immunogen, Inc. Methods of preparing cytotoxic benzodiazepine derivatives
AU2019379104A1 (en) 2018-11-12 2021-06-03 Immunogen, Inc. Methods of preparing cytotoxic benzodiazepine derivatives
EP3947395A1 (en) * 2019-03-29 2022-02-09 ImmunoGen, Inc. Cytotoxic bis-benzodiazepine derivatives and conjugates thereof with cell-binding agents for inhibiting abnormal cell growth or for treating proliferative diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9018601D0 (en) 1990-08-24 1990-10-10 Fujisawa Pharmaceutical Co Tricyclic compounds
NZ610939A (en) 2010-12-21 2014-07-25 Janssen Pharmaceutica Nv Novel antifungal 5,6-dihydro-4h-pyrrolo[1,2-a][1,4]- benzodiazepines and 6h-pyrrolo[1,2-a][1,4]benzodiazepines substituted with bicyclic benzene derivatives
PL2675479T3 (pl) * 2011-02-15 2016-09-30 Cytotoksyczne pochodne benzodiazepiny
WO2016115191A1 (en) 2015-01-14 2016-07-21 Bristol-Myers Squibb Company Benzodiazepine dimers, conjugates thereof, and methods of making and using
KR102663480B1 (ko) * 2015-06-29 2024-05-23 이뮤노젠 아이엔씨 항-cd123 항체 및 이들의 접합체와 유도체
CN108290895B (zh) * 2015-07-21 2021-03-19 伊缪诺金公司 制备细胞毒性苯并二氮杂*衍生物的方法
PL3573948T3 (pl) 2017-01-25 2023-01-30 Immunogen, Inc. Sposoby otrzymywania cytotoksycznych pochodnych benzodiazepiny

Also Published As

Publication number Publication date
IL268213B (en) 2021-12-01
US10844078B2 (en) 2020-11-24
JP2022105096A (ja) 2022-07-12
US20200002360A1 (en) 2020-01-02
SG11201906666QA (en) 2019-08-27
LT3573948T (lt) 2023-02-10
AU2022201572A1 (en) 2022-03-31
WO2018140435A1 (en) 2018-08-02
CN116554262A (zh) 2023-08-08
JP7066725B2 (ja) 2022-05-13
JP2020505404A (ja) 2020-02-20
WO2018140435A9 (en) 2018-12-27
CN110225904A (zh) 2019-09-10
EP3573948B1 (en) 2022-10-05
AU2018213202B2 (en) 2022-03-24
FI3573948T3 (fi) 2023-01-13
TW202400551A (zh) 2024-01-01
TWI805325B (zh) 2023-06-11
RS63871B1 (sr) 2023-02-28
CN116102615A (zh) 2023-05-12
IL268213A (en) 2019-09-26
KR20230005410A (ko) 2023-01-09
HUE060746T2 (hu) 2023-04-28
CA3050262A1 (en) 2018-08-02
US11390633B2 (en) 2022-07-19
IL287405B (en) 2022-07-01
SI3573948T1 (sl) 2023-03-31
JP7400005B2 (ja) 2023-12-18
AU2018213202A1 (en) 2019-08-22
AU2022201572B2 (en) 2024-03-14
ES2935346T3 (es) 2023-03-06
HRP20230002T1 (hr) 2023-02-17
RU2019125133A3 (pt) 2021-05-27
EP3573948A1 (en) 2019-12-04
TWI763771B (zh) 2022-05-11
US20230039161A1 (en) 2023-02-09
DK3573948T3 (da) 2023-01-09
EP4148044A1 (en) 2023-03-15
TW202229226A (zh) 2022-08-01
RU2021138005A (ru) 2022-01-18
KR102480594B1 (ko) 2022-12-26
CN110225904B (zh) 2023-10-27
RU2019125133A (ru) 2021-02-26
IL293645A (en) 2022-08-01
US11981687B2 (en) 2024-05-14
PL3573948T3 (pl) 2023-01-30
JP2024028860A (ja) 2024-03-05
KR20190116331A (ko) 2019-10-14
US10385071B2 (en) 2019-08-20
IL287405A (en) 2021-12-01
TW201831495A (zh) 2018-09-01
US20210139510A1 (en) 2021-05-13
US20180251474A1 (en) 2018-09-06
RU2762891C2 (ru) 2021-12-23
AU2024201119A1 (en) 2024-03-14

Similar Documents

Publication Publication Date Title
IL268737A (en) Processes for the preparation of benzodiapine derivatives
IL291598A (en) History of benzodiazepine cytotoxicity
IL286788B1 (en) Methods for the preparation of cytotoxic benzodiazepine compounds
IL287405A (en) Methods for preparing cytotoxic benzodiazepine derivatives
IL293192A (en) Methods for the preparation of indolinobenzodiazepine derivatives
IL283047A (en) Methods for preparing cytotoxic benzodiazepine derivatives
IL283045A (en) Methods for preparing cytotoxic benzodiazepine derivatives